The Predictive Value of Neurofilament Light Chain Levels in Blood for Cognitive Impairment in Patients with Secondary Progressive Multiple Sclerosis

被引：1
|
作者：
Kuhle, Jens [1 ,2 ,3 ,4 ,5 ]
Kropshofer, Harald [6 ]
Barro, Christian [1 ,2 ,3 ,4 ,5 ]
Meinert, Rolf [7 ]
Haring, Dieter [6 ]
Leppert, David [6 ]
Dahlke, Frank [6 ]
Tomic, Davorka [6 ]
Kappos, Ludwig [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland
[2] Univ Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland
[3] Univ Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland
[4] Univ Hosp, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland
[5] Univ Basel, Basel, Switzerland
[6] Novartis Pharma AG, Basel, Switzerland
[7] DATAMAP GmbH, Freiburg, Germany
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S12.009
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [2] Siponimod Reduces Neurofilament Light Chain Blood Levels in Secondary Progressive Multiple Sclerosis Patients
    Kuhle, Jens
    Kropshofer, Harald
    Barro, Christian
    Meinert, Rolf
    Haring, Dieter A.
    Leppert, David
    Tomic, Davorka
    Dahlke, Frank
    Kappos, Ludwig
    [J]. NEUROLOGY, 2018, 90
  • [3] Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis
    Husseini, Leila
    Jung, Jakob
    Boess, Natalie
    Kruse, Niels
    Nessler, Stefan
    Stadelmann, Christine
    Metz, Imke
    Haupts, Michael
    Weber, Martin S.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [4] Serum neurofilament light chain levels correlate strongly with cognitive status in patients with relapsing and progressive multiple sclerosis
    Edwards, K.
    Kamath, A.
    O'Connor, J.
    Kamath, V.
    Whidden, C.
    Button, A.
    Button, J.
    Bruso, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP6 - NP8
  • [5] Neurofilament Light Chain Levels In Pregnant Multiple Sclerosis Patients
    Pablo Cuello, Juan
    Martinez Gines, Maria Luisa
    Kuhle, Jens
    Garcia Dominguez, Jose Manuel
    Lozano Ros, Alberto
    Romero Delgado, Fernando
    Higueras, Yolanda
    Meldana Rivera, Ariana
    Goicochea Briceno, Haydee
    Garcia Tizon, Santiago
    de-Leon Ruiz, Juan
    Alvarez Lafuente, Roberto
    Inmaculada Dominguez-Mozo, Maria
    Perez-Perez, Silvia
    Heras, Silvia Medina
    Velasco, Jose Ignacio Fernandez
    Tejeda-Velarde, Amalia
    De Andres, Clara
    Villar, Luisa Maria
    [J]. NEUROLOGY, 2019, 92 (15)
  • [6] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Lorenzo Gaetani
    Nicola Salvadori
    Viviana Lisetti
    Paolo Eusebi
    Andrea Mancini
    Lucia Gentili
    Angela Borrelli
    Emilio Portaccio
    Paola Sarchielli
    Kaj Blennow
    Henrik Zetterberg
    Lucilla Parnetti
    Paolo Calabresi
    Massimiliano Di Filippo
    [J]. Journal of Neurology, 2019, 266 : 2157 - 2163
  • [7] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Gaetani, Lorenzo
    Salvadori, Nicola
    Lisetti, Viviana
    Eusebi, Paolo
    Mancini, Andrea
    Gentili, Lucia
    Borrelli, Angela
    Portaccio, Emilio
    Sarchielli, Paola
    Blennow, Kaj
    Zetterberg, Henrik
    Parnetti, Lucilla
    Calabresi, Paolo
    Di Filippo, Massimiliano
    [J]. JOURNAL OF NEUROLOGY, 2019, 266 (09) : 2157 - 2163
  • [8] Examination of the neurofilament light chain in the blood of patients with multiple sclerosis
    Turcani, P.
    Vitkova, M.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2023, 86 (04) : 286 - 287
  • [9] Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
    Bjornevik, Kjetil
    Munger, Kassandra L.
    Cortese, Marianna
    Barro, Christian
    Healy, Brian C.
    Niebuhr, David W.
    Scher, Ann I.
    Kuhle, Jens
    Ascherio, Alberto
    [J]. JAMA NEUROLOGY, 2020, 77 (01) : 58 - 64
  • [10] Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study
    Kapoor, R.
    Sellebjerg, F.
    Hartung, H. -P.
    Arnold, D. L.
    Freedman, M. S.
    Jeffery, D.
    Miller, A.
    Edwards, K. R.
    Singh, C. M.
    Chang, I.
    Ren, Z.
    Sangurdekar, D.
    Zhu, B.
    Sheikh, S.
    Mehta, D.
    Ho, P. -R.
    Campbell, N.
    Edwards, M.
    Fisher, E.
    Kieseier, B. C.
    Rudick, R. A.
    Plavina, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 988 - 988
12345